133 related articles for article (PubMed ID: 22990951)
1. [Image-guided punch biopsy of the prostate].
Seitz M; Gratzke C; Stief C; Tilki D
Aktuelle Urol; 2012 Sep; 43(5):321-9. PubMed ID: 22990951
[TBL] [Abstract][Full Text] [Related]
2. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
Kapustin VV
Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
[TBL] [Abstract][Full Text] [Related]
3. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
4. Additional Targeted Biopsy in Clinically Suspected Prostate Cancer: Prospective Randomized Comparison between Contrast-Enhanced Ultrasound and Sonoelastography Guidance.
Koh J; Jung DC; Oh YT; Yoo MG; Noh S; Han KH; Rha KH; Choi YD; Hong SJ
Ultrasound Med Biol; 2015 Nov; 41(11):2836-41. PubMed ID: 26298036
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer.
Trabulsi EJ; Sackett D; Gomella LG; Halpern EJ
Urology; 2010 Nov; 76(5):1025-33. PubMed ID: 20719368
[TBL] [Abstract][Full Text] [Related]
6. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
[TBL] [Abstract][Full Text] [Related]
7. [Transrectal ultrasound of the prostate. Current status and prospects].
Zacharias M; Jenderka KV; Heynemann H; Fornara P
Urologe A; 2002 Nov; 41(6):559-68. PubMed ID: 12524943
[TBL] [Abstract][Full Text] [Related]
8. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
[TBL] [Abstract][Full Text] [Related]
9. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience.
Kim CK; Park BK; Park W; Kim SS
Abdom Imaging; 2010 Apr; 35(2):246-52. PubMed ID: 19130116
[TBL] [Abstract][Full Text] [Related]
10. [Innovative approaches in prostate cancer ultrasound].
Loch T
Urologe A; 2006 Jun; 45(6):692, 694-8, 700-1. PubMed ID: 16788786
[TBL] [Abstract][Full Text] [Related]
11. [Imaging fusion in the diagnosis of prostate cancer].
Zhang YY; Hu B; Chen L
Zhonghua Nan Ke Xue; 2015 Jan; 21(1):78-81. PubMed ID: 25707146
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate cancer with a microbubble ultrasound contrast agent.
Frauscher F; Klauser A; Halpern EJ; Horninger W; Bartsch G
Lancet; 2001 Jun; 357(9271):1849-50. PubMed ID: 11410195
[TBL] [Abstract][Full Text] [Related]
13. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Cattarino S; Lisi D; Gentilucci A; Alfarone A; Bernardo S; Passariello R; Gentile V
Clin Cancer Res; 2010 Mar; 16(6):1875-83. PubMed ID: 20197480
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
[TBL] [Abstract][Full Text] [Related]
15. [Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results].
Sommerfeld HJ; Garcia-Schürmann JM; Schewe J; Kühne K; Cubick F; Berges RR; Lorenz A; Pesavento A; Scheipers U; Ermert H; Pannek J; Philippou S; Senge T
Urologe A; 2003 Jul; 42(7):941-5. PubMed ID: 12898038
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy.
Mitterberger M; Aigner F; Pinggera GM; Steiner E; Rehder P; Ulmer H; Halpern EJ; Horninger W; Frauscher F
BJU Int; 2010 Nov; 106(9):1315-8; discussion 1318. PubMed ID: 20346032
[TBL] [Abstract][Full Text] [Related]
17. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings.
Cornud F; Hamida K; Flam T; Hélénon O; Chrétien Y; Thiounn N; Correas JM; Casanova JM; Moreau JF
AJR Am J Roentgenol; 2000 Oct; 175(4):1161-8. PubMed ID: 11000183
[TBL] [Abstract][Full Text] [Related]
18. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results.
Jung EM; Wiggermann P; Greis C; Eder F; Ehrich J; Jung W; Schreyer AG; Stroszczynski C; Ganzer R
Clin Hemorheol Microcirc; 2012; 52(2-4):167-77. PubMed ID: 22975940
[TBL] [Abstract][Full Text] [Related]
19. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
[TBL] [Abstract][Full Text] [Related]
20. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
